255 related articles for article (PubMed ID: 19950015)
41. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
Gong T; Xu J; Heng B; Qiu S; Yi B; Han Y; Lo ECM; Zhang C
J Dent Res; 2019 Jul; 98(7):803-812. PubMed ID: 31017515
[TBL] [Abstract][Full Text] [Related]
42. EphB4 forward signalling regulates lymphatic valve development.
Zhang G; Brady J; Liang WC; Wu Y; Henkemeyer M; Yan M
Nat Commun; 2015 Apr; 6():6625. PubMed ID: 25865237
[TBL] [Abstract][Full Text] [Related]
43. Osteoblast and osteoclast crosstalks: from OAF to Ephrin.
Tamma R; Zallone A
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):196-200. PubMed ID: 22280242
[TBL] [Abstract][Full Text] [Related]
44. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J
Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475
[TBL] [Abstract][Full Text] [Related]
45. Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.
Teramachi J; Nagata Y; Mohammad K; Inagaki Y; Ohata Y; Guise T; Michou L; Brown JP; Windle JJ; Kurihara N; Roodman GD
J Clin Invest; 2016 Mar; 126(3):1012-22. PubMed ID: 26878170
[TBL] [Abstract][Full Text] [Related]
46. EphrinB2-EphB4 Signaling in Neurooncological Disease.
Piffko A; Uhl C; Vajkoczy P; Czabanka M; Broggini T
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163601
[TBL] [Abstract][Full Text] [Related]
47. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
Huang X; Yamada Y; Kidoya H; Naito H; Nagahama Y; Kong L; Katoh SY; Li WL; Ueno M; Takakura N
Cancer Res; 2007 Oct; 67(20):9800-8. PubMed ID: 17942910
[TBL] [Abstract][Full Text] [Related]
48. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1.
Zhang JS; Wang YZ; Hu YQ; Lin F; Gao D; Song J; Kaptchuk TJ; Chen KJ
Chin J Integr Med; 2016 Aug; 22(8):605-10. PubMed ID: 27299459
[TBL] [Abstract][Full Text] [Related]
49. EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma.
Randolph ME; Cleary MM; Bajwa Z; Svalina MN; Young MC; Mansoor A; Kaur P; Bult CJ; Goros MW; Michalek JE; Xiang S; Keck J; Krasnoperov V; Gill P; Keller C
PLoS One; 2017; 12(8):e0183161. PubMed ID: 28817624
[TBL] [Abstract][Full Text] [Related]
50. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
51. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.
Scehnet JS; Ley EJ; Krasnoperov V; Liu R; Manchanda PK; Sjoberg E; Kostecke AP; Gupta S; Kumar SR; Gill PS
Blood; 2009 Jan; 113(1):254-63. PubMed ID: 18836096
[TBL] [Abstract][Full Text] [Related]
52. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
Sturz A; Bader B; Thierauch KH; Glienke J
Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
[TBL] [Abstract][Full Text] [Related]
53. Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats.
Sun J; Sun B; Wang W; Han X; Liu H; Du J; Feng W; Liu B; Amizuka N; Li M
J Mol Histol; 2016 Aug; 47(4):389-99. PubMed ID: 27255234
[TBL] [Abstract][Full Text] [Related]
54. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
55. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
Du E; Li X; He S; Li X; He S
Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
[TBL] [Abstract][Full Text] [Related]
56. Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases.
Matsuo K; Otaki N
Cell Adh Migr; 2012; 6(2):148-56. PubMed ID: 22660185
[TBL] [Abstract][Full Text] [Related]
57. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
[TBL] [Abstract][Full Text] [Related]
58. Disturbed Expression of EphB4, but Not EphrinB2, Inhibited Bone Regeneration in an In Vivo Inflammatory Microenvironment.
Shen LL; Zhang LX; Wang LM; Zhou RJ; Yang CZ; Zhang J; Yang PS
Mediators Inflamm; 2016; 2016():6430407. PubMed ID: 28077917
[TBL] [Abstract][Full Text] [Related]
59. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
[TBL] [Abstract][Full Text] [Related]
60. Low-intensity pulsed ultrasound regulates osteoblast-osteoclast crosstalk via EphrinB2/EphB4 signaling for orthodontic alveolar bone remodeling.
Zhou J; Zhu Y; Ai D; Zhou M; Li H; Fu Y; Song J
Front Bioeng Biotechnol; 2023; 11():1192720. PubMed ID: 37425367
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
